Christopher N. Graham, MSc

Health Economic Head
RTI Health Solutions, Research Triangle Park, NC, USA

Poster(s):

• (97) A cost per responder analysis of ritlecitinib and baricitinib: assessing the impact of clinical efficacy and dosing variability on overall treatment costs of severe alopecia areata
  Wednesday, October 29, 2025

• (134) Budget impact of Symbravo® (MoSEIC™ meloxicam and rizatriptan) to health plans in the United States for the acute treatment of migraine in adults
  Wednesday, October 29, 2025